Initial and late resistance to Imatinib (IM) in advanced gastro-intestinal stromal tumors (GIST) are predicted by different prognostic factors. An EORTC-AGITG study

M Glabbeke, Jaap Verweij, PG Casali, A le Cesne, P Hohenberger, I Ray-Coquard, M Schlemmer, AT van Oosterom, DS Goldstein, R Sciot, PCW Hogendoorn, M Brown, R Bertulli, IR Judson

Research output: Contribution to journalArticleAcademicpeer-review

257 Citations (Scopus)
Original languageUndefined/Unknown
Pages (from-to)5795-5804
Number of pages10
JournalJournal of Clinical Oncology
Publication statusPublished - 2005
Externally publishedYes

Cite this